Patent classifications
C12N2533/00
BLOOD VESSEL MIMIC AND METHOD FOR CULTURING BLOOD VESSEL MIMIC
A method for culturing a blood vessel mimic according to an embodiment of the present invention comprises the steps of: printing a lower structure of a chamber; printing a blood vessel mimic on the lower structure; printing an upper structure of the chamber on the lower structure and the blood vessel mimic; connecting, to both ends of the blood vessel mimic, tubes connected to a circulating pump, respectively; and operating the circulating pump to circulate a fluid through the blood vessel mimic.
CELL CULTURE SUBSTRATE HAVING AN ACRYLATE STRUCTURAL UNIT AND A MONOMER STRUCTURAL UNIT
This invention is to provide a means capable of obtaining excellent cell proliferation activity without depending on a thickness of a coating layer in a technique of coating a cell culture substrate (cell culture vessel) using a polymer. Provided is a cell culture substrate comprising a coating layer on at least one surface of a polymer substrate, wherein the coating layer includes a copolymer comprising more than 40% by mole and less than 100% by mole of a structural unit (1) derived from carboxyalkyl (meth)acrylate represented by Formula (1) and more than 0% by mole and less than 60% by mole of a structural unit (2) derived from ethylenically unsaturated monomer having a hydroxyl group (the total of the structural unit (1) and the structural unit (2) is 100% by mole).
CELL CULTURE SUBSTRATE HAVING TWO ACRYLATE STRUCTURAL UNITS
The invention is to provide a means capable of achieving both cellular adhesiveness and antithrombogenicity with balance. Provided is a cell culture substrate comprising a coating layer on at least one side of a polymer substrate, wherein the coating layer includes a copolymer having 5 to 65% by mole of a structural unit (1) derived from alkoxyalkyl (meth)acrylate of Formula (1) and 95 to 35% by mole of a structural unit (2) derived from furfuryl (meth)acrylate of Formula (2) (the total of the structural unit (1) and the structural unit (2) is 100% by mole).
MYOCYTE-DERIVED FLOW ASSIST DEVICE: EXTRAVASAL SHEATHS OF RHYTHMICALLY CONTRACTING MYOCYTES AIDING FLOW OF BIOLOGICAL FLUIDS
This invention relates, e.g., to a Myocyte-based Flow Assist Device (MFAD) for treating a subject in need of increased flow of a biological fluid, such as venous blood or lymph, comprising a sheath which comprises rhythmically contracting myocytes.
SCAFFOLDS TO TREAT SOLID TUMOR CELLS AND ESCAPE VARIANTS
Implantable scaffolds that treat solid tumors and escape variants and that provide effective vaccinations against cancer recurrence are described. The scaffolds include genetically-reprogrammed lymphocytes and a lymphocyte-activating moiety.
System and method for creating tissue
- Christopher C. Langenfeld ,
- David D. B. Cannan ,
- Dirk A. van der Merwe ,
- Dean Kamen ,
- Jason A. Demers ,
- Frederick Morgan ,
- Timothy D. Moreau ,
- Brian D. Tracey ,
- Matthew Ware ,
- Richard J. Lanigan ,
- Michael A. Baker ,
- David Blumberg, Jr. ,
- Richard E. Gautney ,
- Derek G. Kane ,
- Dane Fawkes ,
- Thomas J. Bollenbach ,
- Michael C. TILLEY ,
- Stuart A. JACOBSON ,
- John F. Mannisto
A system and method for growing and maintaining biological material including producing a protein associated with the tissue, selecting cells associated with the tissue, expanding the cells, creating at least one tissue bio-ink including the expanded cells, printing the at least one tissue bio-ink in at least one tissue growth medium mixture, growing the tissue from the printed at least one tissue bio-ink, and maintaining viability of the tissue.
Cell culture method and automatic cell culture apparatus
A novel cell culture method for inducing differentiation of a pluripotent stem cell into trophoblast and an automatic culture apparatus therefor includes: a first step of culturing the pluripotent stem cell in a presence of a ROCK inhibitor during a first time period; a second step of culturing the pluripotent stem cell, which has been subjected to the first step, without the ROCK inhibitor during a second time period following the first time period; and a step of culturing the pluripotent stem cell, which has been subjected to the second step, in the presence of the ROCK inhibitor during a third time period following the second time period, in which the pluripotent stem cell is cultured in a state of being adhered to a cell culture substrate including a planar mesh through the first to third time periods.
PROCESS FOR PROVIDING A CULTURE OF MICROORGANISMS TO AN ELONGATED ELEMENT
The present invention relates to a process for depositing at least a culture of microorganisms to an elongated element, preferably a yarn, comprising the steps of: providing at least a first feeding device comprising at least a first outlet; supplying at least one elongated element to said at least first feeding device; feeding to said first outlet at least a first culture comprising at least one microorganism; dispensing said first culture from said at least first outlet; contacting at least part of said elongated element with said first culture of microorganisms, to provide at least a part of said elongated element with an amount of said first culture of microorganisms.
NANOSTRAW WELL INSERT DEVICES FOR IMPROVED CELL TRANSFECTION AND VIABILITY
Described herein are nanostraw well insert apparatuses (e.g., devices and systems) that include nanotubes extending through and out of a membrane so that a material can pass through the membrane from a fluid reservoir depot and into a cell grown onto the nanotubes when electrical energy (e.g., electroporation energy) is applied. In particular, the device, systems and methods described herein may be adapted for cell growth viability and transfection efficiency (e.g., >70%). These apparatuses may be readily integratable into cell culturing processes for improved transfection efficiency, intracellular transport, and cell viability.
SCAFFOLDS TO TREAT SOLID TUMOR CELLS AND ESCAPE VARIANTS
Implantable scaffolds that treat solid tumors and escape variants and that provide effective vaccinations against cancer recurrence are described. The scaffolds include genetically-reprogrammed lymphocytes and a lymphocyte activating moiety.